|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
289,870,000 |
Market
Cap: |
69.23(B) |
Last
Volume: |
2,081,153 |
Avg
Vol: |
1,407,619 |
52
Week Range: |
$225.07 - $283.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 224 |
Guru Rank Value : 5.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,597 |
9,836 |
17,573 |
47,101 |
Total Sell Value |
$2,028,812 |
$2,316,830 |
$4,382,400 |
$12,101,842 |
Total People Sold |
3 |
3 |
6 |
8 |
Total Sell Transactions |
4 |
5 |
10 |
16 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(672) |
8,658 |
|
- |
|
Mas Ribo Alberto |
EVP and Pres, Life Sciences |
|
2020-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
949 |
9,330 |
|
- |
|
Lim James C |
Executive Vice President |
|
2020-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
802 |
19,768 |
|
- |
|
Campion Simon D |
EVP and Segment President |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(184) |
9,459 |
|
- |
|
Spoerel Thomas J |
VP Controller & Chief Acct Off |
|
2020-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
495 |
1,249 |
|
- |
|
Spoerel Thomas J |
VP Controller & Chief Acct Off |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(222) |
1,011 |
|
- |
|
Larson Betty D |
EVP HR & CHRO |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(164) |
7,173 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(36) |
6,830 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2020-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
266 |
6,866 |
|
- |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(192) |
5,070 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,352) |
17,422 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2020-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,657 |
19,774 |
|
- |
|
Reidy Christopher R |
CFO and EVP of Administration |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,924) |
27,658 |
|
- |
|
Reidy Christopher R |
CFO and EVP of Administration |
|
2020-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,372 |
29,582 |
|
- |
|
Forlenza Vincent A |
Chairman of the Board |
|
2020-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,080) |
194,316 |
|
- |
|
Forlenza Vincent A |
Chairman of the Board |
|
2020-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,969 |
201,396 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2020-11-23 |
4 |
S |
$230.10 |
$213,993 |
D/D |
(930) |
7,994 |
|
-7% |
|
Goette Roland |
EVP and President, EMEA |
|
2020-11-23 |
4 |
D |
$230.10 |
$267,146 |
D/D |
(1,161) |
8,924 |
|
- |
|
Goette Roland |
EVP and President, EMEA |
|
2020-11-23 |
4 |
OE |
$76.64 |
$267,090 |
D/D |
3,485 |
10,085 |
|
- |
|
Forlenza Vincent A |
Chairman of the Board |
|
2020-11-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
462 |
193,427 |
|
- |
|
Forlenza Vincent A |
Chairman of the Board |
|
2020-11-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
104 |
193,889 |
|
- |
|
Forlenza Vincent A |
Chairman of the Board |
|
2020-11-10 |
4 |
GA |
$0.00 |
$0 |
D/D |
7,507 |
193,993 |
|
- |
|
Ezell Antoine C |
EVP, President, NA & CMOOffice |
|
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,141 |
|
10% |
|
Spoerel Thomas J |
VP Controller & Chief Acct Off |
|
2020-09-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(59) |
976 |
|
- |
|
Forlenza Vincent A |
Chairman of the Board |
|
2020-07-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,660 |
186,486 |
|
- |
|
863 Records found
|
|
Page 10 of 35 |
|
|